Eintrag weiter verarbeiten
Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes...
Gespeichert in:
| Zeitschriftentitel: | Journal of Diabetes Investigation |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , , , , , , , , , , |
| In: | Journal of Diabetes Investigation, 10, 2019, 6, S. 1471-1479 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Sugimoto, Ken Tabara, Yasuharu Ikegami, Hiroshi Takata, Yasunori Kamide, Kei Ikezoe, Tome Kiyoshige, Eri Makutani, Yukako Onuma, Hiroshi Gondo, Yasuyuki Ikebe, Kazunori Ichihashi, Noriaki Tsuboyama, Tadao Matsuda, Fumihiko Kohara, Katsuhiko Kabayama, Mai Fukuda, Masahiro Katsuya, Tomohiro Osawa, Haruhiko Hiromine, Yoshihisa Rakugi, Hiromi Sugimoto, Ken Tabara, Yasuharu Ikegami, Hiroshi Takata, Yasunori Kamide, Kei Ikezoe, Tome Kiyoshige, Eri Makutani, Yukako Onuma, Hiroshi Gondo, Yasuyuki Ikebe, Kazunori Ichihashi, Noriaki Tsuboyama, Tadao Matsuda, Fumihiko Kohara, Katsuhiko Kabayama, Mai Fukuda, Masahiro Katsuya, Tomohiro Osawa, Haruhiko Hiromine, Yoshihisa Rakugi, Hiromi |
|---|---|
| author |
Sugimoto, Ken Tabara, Yasuharu Ikegami, Hiroshi Takata, Yasunori Kamide, Kei Ikezoe, Tome Kiyoshige, Eri Makutani, Yukako Onuma, Hiroshi Gondo, Yasuyuki Ikebe, Kazunori Ichihashi, Noriaki Tsuboyama, Tadao Matsuda, Fumihiko Kohara, Katsuhiko Kabayama, Mai Fukuda, Masahiro Katsuya, Tomohiro Osawa, Haruhiko Hiromine, Yoshihisa Rakugi, Hiromi |
| spellingShingle |
Sugimoto, Ken Tabara, Yasuharu Ikegami, Hiroshi Takata, Yasunori Kamide, Kei Ikezoe, Tome Kiyoshige, Eri Makutani, Yukako Onuma, Hiroshi Gondo, Yasuyuki Ikebe, Kazunori Ichihashi, Noriaki Tsuboyama, Tadao Matsuda, Fumihiko Kohara, Katsuhiko Kabayama, Mai Fukuda, Masahiro Katsuya, Tomohiro Osawa, Haruhiko Hiromine, Yoshihisa Rakugi, Hiromi Journal of Diabetes Investigation Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus General Medicine Endocrinology, Diabetes and Metabolism Internal Medicine |
| author_sort |
sugimoto, ken |
| spelling |
Sugimoto, Ken Tabara, Yasuharu Ikegami, Hiroshi Takata, Yasunori Kamide, Kei Ikezoe, Tome Kiyoshige, Eri Makutani, Yukako Onuma, Hiroshi Gondo, Yasuyuki Ikebe, Kazunori Ichihashi, Noriaki Tsuboyama, Tadao Matsuda, Fumihiko Kohara, Katsuhiko Kabayama, Mai Fukuda, Masahiro Katsuya, Tomohiro Osawa, Haruhiko Hiromine, Yoshihisa Rakugi, Hiromi 2040-1116 2040-1124 Wiley General Medicine Endocrinology, Diabetes and Metabolism Internal Medicine http://dx.doi.org/10.1111/jdi.13070 <jats:title>Abstract</jats:title><jats:sec><jats:title>Aims/Introduction</jats:title><jats:p>Hyperglycemia is a risk factor for sarcopenia when comparing individuals with and without diabetes. However, no studies have investigated whether the findings could be extrapolated to patients with diabetes with relatively higher glycemic levels. Here, we aimed to clarify whether glycemic control was associated with sarcopenia in patients with type 2 diabetes.</jats:p></jats:sec><jats:sec><jats:title>Materials and Methods</jats:title><jats:p>Study participants consisted of patients with type 2 diabetes (<jats:italic>n</jats:italic> = 746, the average age was 69.9 years) and an older general population (<jats:italic>n</jats:italic> = 2,067, the average age was 68.2 years). Sarcopenia was defined as weak grip strength or slow usual gait speed and low skeletal mass index.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Among patients with type 2 diabetes, 52 were diagnosed as having sarcopenia. The frequency of sarcopenia increased linearly with glycated hemoglobin (HbA1c) level, particularly in lean individuals (HbA1c <6.5%, 7.0%, ≥6.5% and <7.0%: 18.5%; HbA1c ≥7.0% and <8.0%: 20.3%; HbA1c ≥8.0%: 26.7%). The linear association was independent of major covariates, including anthropometric factors and duration of diabetes (HbA1c <6.5%: reference; ≥6.5% and <7.0%: odds ratio [<jats:styled-content style="fixed-case">OR</jats:styled-content>] 4.38, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.030; HbA1c ≥7.0% and <8.0%: 4.29, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.024; HbA1c ≥8.0%: 7.82, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.003). HbA1c level was specifically associated with low skeletal mass index (HbA1c ≥8.0%: <jats:styled-content style="fixed-case">OR</jats:styled-content> 5.42, <jats:italic>P </jats:italic><<jats:italic> </jats:italic>0.001) rather than weak grip strength (<jats:styled-content style="fixed-case">OR</jats:styled-content> 1.89, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.058) or slow gait speed (<jats:styled-content style="fixed-case">OR</jats:styled-content> 1.13, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.672). No significant association was observed in the general population with a better glycemic profile.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Poor glycemic control in patients with diabetes was associated with low muscle mass.</jats:p></jats:sec> Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus Journal of Diabetes Investigation |
| doi_str_mv |
10.1111/jdi.13070 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qZGkuMTMwNzA |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qZGkuMTMwNzA |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
| imprint |
Wiley, 2019 |
| imprint_str_mv |
Wiley, 2019 |
| issn |
2040-1116 2040-1124 |
| issn_str_mv |
2040-1116 2040-1124 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
sugimoto2019hyperglycemiainnonobesepatientswithtype2diabetesisassociatedwithlowmusclemassthemulticenterstudyforclarifyingevidenceforsarcopeniainpatientswithdiabetesmellitus |
| publishDateSort |
2019 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Diabetes Investigation |
| source_id |
49 |
| title |
Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus |
| title_unstemmed |
Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus |
| title_full |
Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus |
| title_fullStr |
Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus |
| title_full_unstemmed |
Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus |
| title_short |
Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus |
| title_sort |
hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: the multicenter study for clarifying evidence for sarcopenia in patients with diabetes mellitus |
| topic |
General Medicine Endocrinology, Diabetes and Metabolism Internal Medicine |
| url |
http://dx.doi.org/10.1111/jdi.13070 |
| publishDate |
2019 |
| physical |
1471-1479 |
| description |
<jats:title>Abstract</jats:title><jats:sec><jats:title>Aims/Introduction</jats:title><jats:p>Hyperglycemia is a risk factor for sarcopenia when comparing individuals with and without diabetes. However, no studies have investigated whether the findings could be extrapolated to patients with diabetes with relatively higher glycemic levels. Here, we aimed to clarify whether glycemic control was associated with sarcopenia in patients with type 2 diabetes.</jats:p></jats:sec><jats:sec><jats:title>Materials and Methods</jats:title><jats:p>Study participants consisted of patients with type 2 diabetes (<jats:italic>n</jats:italic> = 746, the average age was 69.9 years) and an older general population (<jats:italic>n</jats:italic> = 2,067, the average age was 68.2 years). Sarcopenia was defined as weak grip strength or slow usual gait speed and low skeletal mass index.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Among patients with type 2 diabetes, 52 were diagnosed as having sarcopenia. The frequency of sarcopenia increased linearly with glycated hemoglobin (HbA1c) level, particularly in lean individuals (HbA1c <6.5%, 7.0%, ≥6.5% and <7.0%: 18.5%; HbA1c ≥7.0% and <8.0%: 20.3%; HbA1c ≥8.0%: 26.7%). The linear association was independent of major covariates, including anthropometric factors and duration of diabetes (HbA1c <6.5%: reference; ≥6.5% and <7.0%: odds ratio [<jats:styled-content style="fixed-case">OR</jats:styled-content>] 4.38, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.030; HbA1c ≥7.0% and <8.0%: 4.29, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.024; HbA1c ≥8.0%: 7.82, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.003). HbA1c level was specifically associated with low skeletal mass index (HbA1c ≥8.0%: <jats:styled-content style="fixed-case">OR</jats:styled-content> 5.42, <jats:italic>P </jats:italic><<jats:italic> </jats:italic>0.001) rather than weak grip strength (<jats:styled-content style="fixed-case">OR</jats:styled-content> 1.89, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.058) or slow gait speed (<jats:styled-content style="fixed-case">OR</jats:styled-content> 1.13, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.672). No significant association was observed in the general population with a better glycemic profile.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Poor glycemic control in patients with diabetes was associated with low muscle mass.</jats:p></jats:sec> |
| container_issue |
6 |
| container_start_page |
1471 |
| container_title |
Journal of Diabetes Investigation |
| container_volume |
10 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792347169593753614 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:50:46.255Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Hyperglycemia+in+non%E2%80%90obese+patients+with+type%C2%A02+diabetes+is+associated+with+low+muscle+mass%3A+The+Multicenter+Study+for+Clarifying+Evidence+for+Sarcopenia+in+Patients+with+Diabetes+Mellitus&rft.date=2019-11-01&genre=article&issn=2040-1124&volume=10&issue=6&spage=1471&epage=1479&pages=1471-1479&jtitle=Journal+of+Diabetes+Investigation&atitle=Hyperglycemia+in+non%E2%80%90obese+patients+with+type%C2%A02+diabetes+is+associated+with+low+muscle+mass%3A+The+Multicenter+Study+for+Clarifying+Evidence+for+Sarcopenia+in+Patients+with+Diabetes+Mellitus&aulast=Rakugi&aufirst=Hiromi&rft_id=info%3Adoi%2F10.1111%2Fjdi.13070&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792347169593753614 |
| author | Sugimoto, Ken, Tabara, Yasuharu, Ikegami, Hiroshi, Takata, Yasunori, Kamide, Kei, Ikezoe, Tome, Kiyoshige, Eri, Makutani, Yukako, Onuma, Hiroshi, Gondo, Yasuyuki, Ikebe, Kazunori, Ichihashi, Noriaki, Tsuboyama, Tadao, Matsuda, Fumihiko, Kohara, Katsuhiko, Kabayama, Mai, Fukuda, Masahiro, Katsuya, Tomohiro, Osawa, Haruhiko, Hiromine, Yoshihisa, Rakugi, Hiromi |
| author_facet | Sugimoto, Ken, Tabara, Yasuharu, Ikegami, Hiroshi, Takata, Yasunori, Kamide, Kei, Ikezoe, Tome, Kiyoshige, Eri, Makutani, Yukako, Onuma, Hiroshi, Gondo, Yasuyuki, Ikebe, Kazunori, Ichihashi, Noriaki, Tsuboyama, Tadao, Matsuda, Fumihiko, Kohara, Katsuhiko, Kabayama, Mai, Fukuda, Masahiro, Katsuya, Tomohiro, Osawa, Haruhiko, Hiromine, Yoshihisa, Rakugi, Hiromi, Sugimoto, Ken, Tabara, Yasuharu, Ikegami, Hiroshi, Takata, Yasunori, Kamide, Kei, Ikezoe, Tome, Kiyoshige, Eri, Makutani, Yukako, Onuma, Hiroshi, Gondo, Yasuyuki, Ikebe, Kazunori, Ichihashi, Noriaki, Tsuboyama, Tadao, Matsuda, Fumihiko, Kohara, Katsuhiko, Kabayama, Mai, Fukuda, Masahiro, Katsuya, Tomohiro, Osawa, Haruhiko, Hiromine, Yoshihisa, Rakugi, Hiromi |
| author_sort | sugimoto, ken |
| container_issue | 6 |
| container_start_page | 1471 |
| container_title | Journal of Diabetes Investigation |
| container_volume | 10 |
| description | <jats:title>Abstract</jats:title><jats:sec><jats:title>Aims/Introduction</jats:title><jats:p>Hyperglycemia is a risk factor for sarcopenia when comparing individuals with and without diabetes. However, no studies have investigated whether the findings could be extrapolated to patients with diabetes with relatively higher glycemic levels. Here, we aimed to clarify whether glycemic control was associated with sarcopenia in patients with type 2 diabetes.</jats:p></jats:sec><jats:sec><jats:title>Materials and Methods</jats:title><jats:p>Study participants consisted of patients with type 2 diabetes (<jats:italic>n</jats:italic> = 746, the average age was 69.9 years) and an older general population (<jats:italic>n</jats:italic> = 2,067, the average age was 68.2 years). Sarcopenia was defined as weak grip strength or slow usual gait speed and low skeletal mass index.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Among patients with type 2 diabetes, 52 were diagnosed as having sarcopenia. The frequency of sarcopenia increased linearly with glycated hemoglobin (HbA1c) level, particularly in lean individuals (HbA1c <6.5%, 7.0%, ≥6.5% and <7.0%: 18.5%; HbA1c ≥7.0% and <8.0%: 20.3%; HbA1c ≥8.0%: 26.7%). The linear association was independent of major covariates, including anthropometric factors and duration of diabetes (HbA1c <6.5%: reference; ≥6.5% and <7.0%: odds ratio [<jats:styled-content style="fixed-case">OR</jats:styled-content>] 4.38, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.030; HbA1c ≥7.0% and <8.0%: 4.29, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.024; HbA1c ≥8.0%: 7.82, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.003). HbA1c level was specifically associated with low skeletal mass index (HbA1c ≥8.0%: <jats:styled-content style="fixed-case">OR</jats:styled-content> 5.42, <jats:italic>P </jats:italic><<jats:italic> </jats:italic>0.001) rather than weak grip strength (<jats:styled-content style="fixed-case">OR</jats:styled-content> 1.89, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.058) or slow gait speed (<jats:styled-content style="fixed-case">OR</jats:styled-content> 1.13, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.672). No significant association was observed in the general population with a better glycemic profile.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Poor glycemic control in patients with diabetes was associated with low muscle mass.</jats:p></jats:sec> |
| doi_str_mv | 10.1111/jdi.13070 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qZGkuMTMwNzA |
| imprint | Wiley, 2019 |
| imprint_str_mv | Wiley, 2019 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
| issn | 2040-1116, 2040-1124 |
| issn_str_mv | 2040-1116, 2040-1124 |
| language | English |
| last_indexed | 2024-03-01T17:50:46.255Z |
| match_str | sugimoto2019hyperglycemiainnonobesepatientswithtype2diabetesisassociatedwithlowmusclemassthemulticenterstudyforclarifyingevidenceforsarcopeniainpatientswithdiabetesmellitus |
| mega_collection | Wiley (CrossRef) |
| physical | 1471-1479 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Journal of Diabetes Investigation |
| source_id | 49 |
| spelling | Sugimoto, Ken Tabara, Yasuharu Ikegami, Hiroshi Takata, Yasunori Kamide, Kei Ikezoe, Tome Kiyoshige, Eri Makutani, Yukako Onuma, Hiroshi Gondo, Yasuyuki Ikebe, Kazunori Ichihashi, Noriaki Tsuboyama, Tadao Matsuda, Fumihiko Kohara, Katsuhiko Kabayama, Mai Fukuda, Masahiro Katsuya, Tomohiro Osawa, Haruhiko Hiromine, Yoshihisa Rakugi, Hiromi 2040-1116 2040-1124 Wiley General Medicine Endocrinology, Diabetes and Metabolism Internal Medicine http://dx.doi.org/10.1111/jdi.13070 <jats:title>Abstract</jats:title><jats:sec><jats:title>Aims/Introduction</jats:title><jats:p>Hyperglycemia is a risk factor for sarcopenia when comparing individuals with and without diabetes. However, no studies have investigated whether the findings could be extrapolated to patients with diabetes with relatively higher glycemic levels. Here, we aimed to clarify whether glycemic control was associated with sarcopenia in patients with type 2 diabetes.</jats:p></jats:sec><jats:sec><jats:title>Materials and Methods</jats:title><jats:p>Study participants consisted of patients with type 2 diabetes (<jats:italic>n</jats:italic> = 746, the average age was 69.9 years) and an older general population (<jats:italic>n</jats:italic> = 2,067, the average age was 68.2 years). Sarcopenia was defined as weak grip strength or slow usual gait speed and low skeletal mass index.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Among patients with type 2 diabetes, 52 were diagnosed as having sarcopenia. The frequency of sarcopenia increased linearly with glycated hemoglobin (HbA1c) level, particularly in lean individuals (HbA1c <6.5%, 7.0%, ≥6.5% and <7.0%: 18.5%; HbA1c ≥7.0% and <8.0%: 20.3%; HbA1c ≥8.0%: 26.7%). The linear association was independent of major covariates, including anthropometric factors and duration of diabetes (HbA1c <6.5%: reference; ≥6.5% and <7.0%: odds ratio [<jats:styled-content style="fixed-case">OR</jats:styled-content>] 4.38, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.030; HbA1c ≥7.0% and <8.0%: 4.29, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.024; HbA1c ≥8.0%: 7.82, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.003). HbA1c level was specifically associated with low skeletal mass index (HbA1c ≥8.0%: <jats:styled-content style="fixed-case">OR</jats:styled-content> 5.42, <jats:italic>P </jats:italic><<jats:italic> </jats:italic>0.001) rather than weak grip strength (<jats:styled-content style="fixed-case">OR</jats:styled-content> 1.89, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.058) or slow gait speed (<jats:styled-content style="fixed-case">OR</jats:styled-content> 1.13, <jats:italic>P </jats:italic>=<jats:italic> </jats:italic>0.672). No significant association was observed in the general population with a better glycemic profile.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Poor glycemic control in patients with diabetes was associated with low muscle mass.</jats:p></jats:sec> Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus Journal of Diabetes Investigation |
| spellingShingle | Sugimoto, Ken, Tabara, Yasuharu, Ikegami, Hiroshi, Takata, Yasunori, Kamide, Kei, Ikezoe, Tome, Kiyoshige, Eri, Makutani, Yukako, Onuma, Hiroshi, Gondo, Yasuyuki, Ikebe, Kazunori, Ichihashi, Noriaki, Tsuboyama, Tadao, Matsuda, Fumihiko, Kohara, Katsuhiko, Kabayama, Mai, Fukuda, Masahiro, Katsuya, Tomohiro, Osawa, Haruhiko, Hiromine, Yoshihisa, Rakugi, Hiromi, Journal of Diabetes Investigation, Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus, General Medicine, Endocrinology, Diabetes and Metabolism, Internal Medicine |
| title | Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus |
| title_full | Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus |
| title_fullStr | Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus |
| title_full_unstemmed | Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus |
| title_short | Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus |
| title_sort | hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: the multicenter study for clarifying evidence for sarcopenia in patients with diabetes mellitus |
| title_unstemmed | Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus |
| topic | General Medicine, Endocrinology, Diabetes and Metabolism, Internal Medicine |
| url | http://dx.doi.org/10.1111/jdi.13070 |